Navigation Links
U.S. Preventive Medicine Acquires Specialty Disease Management
Date:10/2/2007

DALLAS, Oct. 2 /PRNewswire/ -- U.S. Preventive Medicine(R) (http://www.USPreventiveMedicine.com) a company organizing and commercializing the market for proactive preventive health services, announced today the acquisition of Specialty Disease Management Services, Inc., a national provider of chronic condition and health management services based in Jacksonville, Fla. Terms of the deal were not disclosed.

The addition of Specialty Disease Management's leading-edge care management programs will enable U.S. Preventive Medicine to continue the expansion of its national network of integrated services and methodologies in the areas of preventive services, health benefits and chronic and complex disease management. To meet consumers and government demand for a larger focus on preventive medicine, U.S. Preventive Medicine is building a national brand of healthcare solutions by partnering with physicians, health systems, academic medical centers, government agencies and employers.

"We believe that current outcomes can be enhanced through the implementation of clinically proven preventive and care management solutions. Specialty Disease Management has developed a unique model for disease management that complements U.S. Preventive Medicine's prevention delivery capabilities," said Brian Baum, President and COO of U.S. Preventive Medicine. "We have a strong history and working relationship with Specialty Disease Management's team in achieving successful healthcare solutions. The combination of a proven team along with the delivery of personalized preventive health and comprehensive care management will allow us to offer the highest level of value."

Specialty Disease Management Services' business model, proven in government and commercial markets, incorporates highly trained clinical staff working with patients and their physicians over the phone and in the community. Their programs includ
'/>"/>

SOURCE U.S. Preventive Medicine
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
2. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
3. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
8. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
9. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
10. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ... Report on China,s Bevacizumab Market ,2010-2019" report to ... trade name of Avastin, bevacizumab injection is the first ... was approved by CFDA to treat metastatic colorectal cancer. ... all come from Roche and its subsidiary Genectech. ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Bevacizumab Market 2015-2019 2
... June 15 Halt Medical, Inc., today announced that the ... Electrosurgical System for soft tissue ablation using radiofrequency energy.  "This clearance ... investors," said Russ DeLonzor , President and Chief Operating Officer.  ... Radiofrequency ...
... WAYNE, N.J. , June 15 Today, Bayer HealthCare ... Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern ... and patent infringement in connection with Teva,s generic oral contraceptive, Gianvi™. ... leading oral contraceptive YAZ ® .   , ...
Cached Medicine Technology:Halt Medical, Inc. Receives FDA Clearance 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 3Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 4Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 5
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been ... Place, N.Y. "I specialize in manual therapy, and my invention will provide headache ... used for additional muscle dysfunction throughout the body." , They developed THE RELIEVER ...
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department ... qualified for the position they are applying for, they are unable to pass the ... are considering altering drug testing policies in order to be able to hire long-term, ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... work Scientists now been able to map the most common ... face of future medicine. ,The study called 'HapMap' study ... genetic differences between 269 individuals that originate from different ... Western Europe. The study involved more than 200 scientists ...
... tea is produced from the leaves of the evergreen ... green tea are polyphenolic compounds, known as catechins. Catechins ... dry // ht, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin ... accounts for approximately 50% of the total amounts of ...
... which can be used to reveal the strength of ... assessing// the likelihood of fracturing a particular bone, an ... Research, says. ,Scientists have developed a laser imaging ... bone density thereby predicting future risk of fracturing that ...
... A bacterium strain known as Helicobacter pylori may raise ... study.// ,Two-thirds of the world population carries H. ... for 25 percent of all childhood cancers worldwide. Acute ... childhood leukaemia. ,Clusters of ALL often occur in ...
... The discovery by a young boy of 22 dead geese at ... may have already found its way into the country, though officials ... the town of Neuwied wore biological protection suits to scoop up ... them in metal boxes to the laboratory in nearby Koblenz run ...
... contamination in herbal/ayurvedic medicines, testing of levels of such ... Indian Government has already issued a notification to test ... meant for products meant for export. It is likely ... as well. ,The Department of Ayurveda, Yoga ...
Cached Medicine News:Health News:Catechins in green tea show antiviral effect on influenza virus 2Health News:Birds Flu Scare Reaches Germany 2
... The model 55S Rocking Shaker ... gels and blotted membranes. The very ... adjustable degree of tilt provide a ... washes over gels and blotted membranes ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
... 96 can incubate and shake up to 16 ... at a time. This new system is ... such as Proteinase K digestion. Now you ... preparing your samples with our AutoIncubator 96 and ...
Inquire...
Medicine Products: